Effect of once‐weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: A post hoc analysis of the EXSCEL trial

The effects of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) on renal outcomes in patients with type 2 diabetes at high cardiovascular risk are modest or neutral. However, GLP‐1RAs may confer clinical benefits in those at high risk of progressive renal function loss. We examined the effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Aart‐van der Beek, Annemarie B., Clegg, Lindsay E., Penland, Robert C., Boulton, David W., Sjöström, C. David, Mentz, Robert J., Holman, Rury R., Heerspink, Hiddo J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756541/
https://www.ncbi.nlm.nih.gov/pubmed/32803900
http://dx.doi.org/10.1111/dom.14175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756541/
https://www.ncbi.nlm.nih.gov/pubmed/32803900
http://dx.doi.org/10.1111/dom.14175

Ejemplares similares